Enterprise Value

43.3M

Cash

16.51M

Avg Qtr Burn

-8.866M

Short % of Float

3.18%

Insider Ownership

39.16%

Institutional Own.

4.50%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

PDUFA

Approval decision

Phase 3

Data readout

NRX-101 Details
Bipolar depression, Acute Suicidal Ideation and Behavior

Phase 3

Data readout

NRX-100 (Ketamine Hydrochloride) Details
Bipolar depression, Acute Suicidal Ideation and Behavior

Phase 3

Initiation

NRX-101 Details
Acute Suicidal Ideation and Behavior, Bipolar depression

Phase 2/3

Data readout

NRX-101 Details
Post-traumatic stress disorder

Phase 2

Data readout

Failed

Discontinued